Anticardiac antibodies in patients with severe and moderate COVID-19 (correlations with the clinical performance and prognosis)
The level and significance of anticardiac antibodies (ACA) in patients with COVID-19 infection have not yet been studied.Aim. To assess the level of various ACA in patients with severe and moderate COVID-19 infection and to identify the correlation of antibody profile with the clinical performance a...
| Main Authors: | , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | Russian |
| 出版: |
«FIRMA «SILICEA» LLC
2020-12-01
|
| 丛编: | Российский кардиологический журнал |
| 主题: | |
| 在线阅读: | https://russjcardiol.elpub.ru/jour/article/view/4054 |